- Home
- SCOR vs PYPD Comparison
SCOR vs PYPD Comparison
Compare SCOR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- PYPD
- Stock Information
- Founded
- SCOR 1999
- PYPD 2008
- Country
- SCOR United States
- PYPD Israel
- Employees
- SCOR N/A
- PYPD N/A
- Industry
- SCOR Business Services
- PYPD Medical/Dental Instruments
- Sector
- SCOR Consumer Discretionary
- PYPD Health Care
- Exchange
- SCOR Nasdaq
- PYPD Nasdaq
- Market Cap
- SCOR 29.0M
- PYPD 30.1M
- IPO Year
- SCOR 2007
- PYPD 2020
- Fundamental
- Price
- SCOR $6.67
- PYPD $2.75
- Analyst Decision
- SCOR Buy
- PYPD Strong Buy
- Analyst Count
- SCOR 2
- PYPD 2
- Target Price
- SCOR $10.75
- PYPD $10.50
- AVG Volume (30 Days)
- SCOR 18.4K
- PYPD 13.1K
- Earning Date
- SCOR 03-04-2025
- PYPD 05-07-2025
- Dividend Yield
- SCOR N/A
- PYPD N/A
- EPS Growth
- SCOR N/A
- PYPD N/A
- EPS
- SCOR N/A
- PYPD N/A
- Revenue
- SCOR $356,047,000.00
- PYPD N/A
- Revenue This Year
- SCOR $4.01
- PYPD N/A
- Revenue Next Year
- SCOR $4.03
- PYPD N/A
- P/E Ratio
- SCOR N/A
- PYPD N/A
- Revenue Growth
- SCOR N/A
- PYPD N/A
- 52 Week Low
- SCOR $4.89
- PYPD $2.37
- 52 Week High
- SCOR $16.41
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- SCOR 50.70
- PYPD 44.19
- Support Level
- SCOR $6.42
- PYPD $2.66
- Resistance Level
- SCOR $7.02
- PYPD $2.97
- Average True Range (ATR)
- SCOR 0.47
- PYPD 0.13
- MACD
- SCOR 0.05
- PYPD -0.02
- Stochastic Oscillator
- SCOR 43.40
- PYPD 20.86
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.